MedRx Co. Ltd. reported consolidated earnings results for the six months ended June 30, 2017. For the six months, the company reported net sales of JPY 18 million compared to JPY 10 million a year ago. Operating loss was JPY 514 million compared to JPY 742 million a year ago. Ordinary loss was JPY 519 million compared to JPY 731 million a year ago. Loss attributable to owners of parent was JPY 477 million or JPY 56.12 per share compared to JPY 707 million or JPY 92.10 per share a year ago.

For the year ending December 2017, the company forecasts consolidated net sales of JPY 186 million, operating loss of JPY 1,261 million, ordinary loss of JPY 1,244 million and loss attributable to owners of parent of JPY 1,206 million or JPY 141.70 per share.